Parkinson Meds Flashcards
Characteristic features of Parkinson
Tremor
Rigidity
Badykinesia
Postural instability
What happens as a result of complications of Parkinson
Death
What is the pathophys of Parkinson
Loss of dopaminergic neurons in substantia nigra
What percent of pts develop motor complications of Parkinson
50-90% of pts on levodopa >5 years develop motor complications
How to deal with wearing off of levodopa effect
Initially: treat by more frequent dosing
Later: add dopamine agonist
How to deal w/ on-off effect of levodopa
Treat w/ rescue apomorphine or adjust dose/frequency of dosing
Describe the physical disability associated with Parkinson
Progressive
Unavoidable
Highly individualized***
Levoadopa (LD)
Mainstay of tx since the 1960s
DOES cross blood brain barrier (BBB)
Does LD have peripheral effects?
Yes
Ex: dyskinesias, NV, etc.
What do you always administer LD with?
Peripheral dopa decarboxylase (DDC) inhibitor
Ex: Carbidopa
What does LD compete w/ for absorption?
Other amino acids
GI upset with LD?
Yes, but minimized
How is LD best absorbed
W/ low protein meals
Peripheral dopa decarboxylase inhibitor agent
Carbidopa
COMT-Inhibitor Agents
Entacapone
Tolcapone
**good peripherally and centrally
MAO-B Inhibitor Agents
Selegiline
Rasagline
Carbidopa
Available alone or in combo w/ Levodopa
Sinemet
Carbidopa dosing
75-100 mg CD/d usually needed to inhibit peripheral DDC
*Usually start w/ IR product of 25/100 mg Sinemet TID
What dose of Levodopa do most pts respond to?
750-1000 mg of LD
After 8 Tabs/day of 25/100 mg Sinemet -> switch to to 1 tab of 25/250 TID
Carbidopa/Levodopa (SInemet) forms
Immediate release (generic) Sustained release (generic) Orally disintegrating (generic)